Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 54

1.

Biofilm lifestyle of Candida: a mini review.

Seneviratne CJ, Jin L, Samaranayake LP.

Oral Dis. 2008 Oct;14(7):582-90. doi: 10.1111/j.1601-0825.2007.01424.x. Review.

PMID:
19076549
2.

Molecular mechanisms of mechanosensing and their roles in fungal contact sensing.

Kumamoto CA.

Nat Rev Microbiol. 2008 Sep;6(9):667-73. doi: 10.1038/nrmicro1960. Review.

3.

Cell density and cell aging as factors modulating antifungal resistance of Candida albicans biofilms.

Seneviratne CJ, Jin LJ, Samaranayake YH, Samaranayake LP.

Antimicrob Agents Chemother. 2008 Sep;52(9):3259-66. doi: 10.1128/AAC.00541-08. Epub 2008 Jul 14.

4.

In vitro efficacies of caspofungin or micafungin catheter lock solutions on Candida albicans biofilm growth.

Cateau E, Rodier MH, Imbert C.

J Antimicrob Chemother. 2008 Jul;62(1):153-5. doi: 10.1093/jac/dkn160. Epub 2008 Apr 10.

PMID:
18407917
5.

Update on echinocandin antifungals.

Kauffman CA, Carver PL.

Semin Respir Crit Care Med. 2008 Apr;29(2):211-9. doi: 10.1055/s-2008-1063859. Review.

PMID:
18366002
6.

Attenuation of echinocandin activity at elevated concentrations: a review of the paradoxical effect.

Wiederhold NP.

Curr Opin Infect Dis. 2007 Dec;20(6):574-8. Review.

PMID:
17975406
7.

Differential activities of newer antifungal agents against Candida albicans and Candida parapsilosis biofilms.

Katragkou A, Chatzimoschou A, Simitsopoulou M, Dalakiouridou M, Diza-Mataftsi E, Tsantali C, Roilides E.

Antimicrob Agents Chemother. 2008 Jan;52(1):357-60. Epub 2007 Oct 15.

8.

A comparative evaluation of properties and clinical efficacy of the echinocandins.

Kim R, Khachikian D, Reboli AC.

Expert Opin Pharmacother. 2007 Jul;8(10):1479-92. Review.

PMID:
17661730
9.

Paradoxical growth effect of caspofungin observed on biofilms and planktonic cells of five different Candida species.

Melo AS, Colombo AL, Arthington-Skaggs BA.

Antimicrob Agents Chemother. 2007 Sep;51(9):3081-8. Epub 2007 Jun 25.

10.

Role for cell density in antifungal drug resistance in Candida albicans biofilms.

Perumal P, Mekala S, Chaffin WL.

Antimicrob Agents Chemother. 2007 Jul;51(7):2454-63. Epub 2007 May 14.

11.

Epidemiology of invasive candidiasis: a persistent public health problem.

Pfaller MA, Diekema DJ.

Clin Microbiol Rev. 2007 Jan;20(1):133-63. Review.

12.

Persister cells, dormancy and infectious disease.

Lewis K.

Nat Rev Microbiol. 2007 Jan;5(1):48-56. Epub 2006 Dec 4. Review.

PMID:
17143318
13.

Putative role of beta-1,3 glucans in Candida albicans biofilm resistance.

Nett J, Lincoln L, Marchillo K, Massey R, Holoyda K, Hoff B, VanHandel M, Andes D.

Antimicrob Agents Chemother. 2007 Feb;51(2):510-20. Epub 2006 Nov 27.

14.

How to build a biofilm: a fungal perspective.

Blankenship JR, Mitchell AP.

Curr Opin Microbiol. 2006 Dec;9(6):588-94. Epub 2006 Oct 20. Review.

PMID:
17055772
16.

Candida albicans biofilms produce antifungal-tolerant persister cells.

LaFleur MD, Kumamoto CA, Lewis K.

Antimicrob Agents Chemother. 2006 Nov;50(11):3839-46. Epub 2006 Aug 21.

17.

Evaluation of caspofungin and amphotericin B deoxycholate against Candida albicans biofilms in an experimental intravascular catheter infection model.

Shuford JA, Rouse MS, Piper KE, Steckelberg JM, Patel R.

J Infect Dis. 2006 Sep 1;194(5):710-3. Epub 2006 Jul 28.

PMID:
16897672
18.

Anti-metabolic activity of caspofungin against Candida albicans and Candida parapsilosis biofilms.

Cocuaud C, Rodier MH, Daniault G, Imbert C.

J Antimicrob Chemother. 2005 Sep;56(3):507-12. Epub 2005 Jul 22.

PMID:
16040622
19.

Specialized persister cells and the mechanism of multidrug tolerance in Escherichia coli.

Keren I, Shah D, Spoering A, Kaldalu N, Lewis K.

J Bacteriol. 2004 Dec;186(24):8172-80.

20.

Candida biofilm resistance.

Mukherjee PK, Chandra J.

Drug Resist Updat. 2004 Aug-Oct;7(4-5):301-9. Review.

PMID:
15533767

Supplemental Content

Support Center